Accomplished scientist with over 11 years of experience in clinical research and psychopharmacology, specializing in cannabinoid research. Proven track record in designing and coordinating clinical trials, managing cross-functional teams, and ensuring regulatory compliance. Published researcher with 430+ citations across peer-reviewed journals. Currently leading scientific operations as Chief Scientific Officer at Bedrocan, driving innovation in pharmaceutical-grade cannabis and cannabis-based medicines research.